Clinical Trial Update: Nordic Study on the Effects of Growth Hormone (Norditropin SimpleXx) Treatment in Adults With Prader-Willi Syndrome [NA]

View source ↗

Summary

This update reports on a completed Nordic study evaluating the effects of growth hormone (Norditropin SimpleXx) in adults with Prader-Willi Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• Norditropin SimpleXx (somatropin)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Prader-Willi Syndrome | NA | Status: COMPLETED